Interventional Oncology Market to Reach $4.38 Billion by 2030 at CAGR 8.55% - Grand View Research, Inc. [Yahoo! Finance]
TERUMO CORP UNSP/ADR (TRUMY)
NASDAQ:AMEX Investor Relations:
terumo.com/investor/library/index.html
Company Research
Source: Yahoo! Finance
a CAGR of 8.55% from 2025 to 2030 , according to a new report by Grand View Research, Inc. This significant expansion is primarily fueled by the rising global cancer burden, with new cases estimated at 20 million in 2022 and forecast to surge to over 35 million by 2050, a 77% increase. Other key market drivers include technological advancements in minimally invasive procedures, a growing geriatric population, a heightened focus on early cancer detection, and increasing public and private investments in the field. Grand View Research, Inc. (PRNewsfoto/Grand View Research, Inc.) Interventional oncology offers a crucial, minimally invasive alternative to traditional cancer treatments like surgery, radiation, and chemotherapy. Utilizing techniques such as radiofrequency ablation (RFA), transarterial chemoembolization (TACE), and cryoablation, these procedures provide significant benefits for patients, including reduced recovery times and lower complication rates compared to convention
Show less
Read more
Impact Snapshot
Event Time:
TRUMY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TRUMY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TRUMY alerts
High impacting TERUMO CORP UNSP/ADR news events
Weekly update
A roundup of the hottest topics
TRUMY
News
- Terumo (TSE:4543): Evaluating Value After Prolonged Share Price Decline [Yahoo! Finance]Yahoo! Finance
- Terumo reports 1H results [Seeking Alpha]Seeking Alpha
- OrganOx Completes Acquisition by Terumo Corporation to Advance the Future of Organ TransplantationGlobeNewswire
- Geisinger and Terumo Neuro Advance Stroke Education and Neurovascular Innovation in Recognition of World Stroke Day 2025PR Newswire
- Terumo Interventional Systems Announces Its New OPUSWAVE® Dual Sensor Imaging System and DualView® Imaging Catheter Receive FDA 510(k) ClearancePR Newswire